Printing Life: Microvascular Networks at Capillary Scale

3D PrintingPublishing & Print MediaAI & Machine Learning

Imagine building a living blood vessel network down to the size of a single capillary—now it’s possible with a new hybrid bioprinting approach.

TL;DR
• Hybrid bioprinting combines aerosol jet and extrusion printing with machine learning for sub‑10‑µm vascular channels.
• Bayesian optimization rapidly tunes parameters, reducing trial‑and‑error.
• Endothelial cells form functional monolayers, lowering permeability while maintaining viability.

Summary
Hybrid bioprinting merges aerosol‑jet sacrificial printing with extrusion of tissue matrices to achieve sub‑10 µm capillary channels, enabling on‑demand vessel diameter control and hierarchical network fabrication. Constrained Bayesian optimization rapidly determines printing parameters, eliminating extensive trial‑and‑error while maintaining reproducibility across one‑dimensional conduits to three‑dimensional branched structures. Endothelial seeding yields continuous monolayers that lower permeability, sustain high viability, and support proliferation, demonstrating functional barrier formation at microvascular scales.
• Deploy constrained Bayesian optimization for each new material system to guarantee target geometry without excessive experimentation.
• Integrate real‑time monitoring of channel dimensions during printing to detect deviations and trigger immediate parameter adjustments.
• Establish a standardized post‑printing endothelial seeding protocol that includes viability assays and permeability testing before clinical translation.
• Document all algorithmic decisions and data sets in an accessible repository to ensure transparency and facilitate external validation.
• Implement a formal complaint and redress workflow for end‑users reporting inconsistencies in printed vascular performance.

The workflow begins with aerosol‑jet deposition of a sacrificial ink, followed by extrusion of a cell‑compatible hydrogel matrix. Machine‑learning models predict optimal nozzle speed, ink flow, and substrate temperature, achieving precise channel dimensions confirmed by bright‑field and fluorescence imaging. Subsequent removal of the sacrificial material reveals perfusable networks, which are then seeded with endothelial cells that form tight junctions, as evidenced by CD31 and F‑actin staining.

Functional assessments show a marked reduction in permeability compared with non‑endothelialized channels, while live‑cell imaging confirms sustained proliferation over multiple days. Data and custom code are available upon reasonable request, supporting reproducibility and further development. Funding from NIH and NSF underpins the project, and conflict‑of‑interest disclosures are managed by institutional review. The study positions this hybrid bioprinting platform as a scalable, ethically accountable solution for tissue engineering, regenerative medicine, and drug discovery applications.

How will this precise, AI‑driven vascular printing reshape regenerative medicine and drug testing?